Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$39.0M
four quarters, 2025-09-01 to 2026-08-31
Revenue, TTM TAYD
FY May 2026
$41.6M
FY May 2025
$46.3M
FY May 2024
$44.6M
FY May 2023
$40.2M
FY May 2022
$30.9M
Aug 2026
$7.3M
May 2026
$9.0M
Feb 2026
$11.2M
Nov 2025
$11.6M
Aug 2025
$9.9M
May 2025
$15.6M
Feb 2025
$10.6M
Nov 2024
$8.5M
At each fiscal year end
Single quarter
Net margin, TTM
+17.5%
net income over revenue, 2025-09-01 to 2026-08-31
Net margin, TTM TAYD
FY May 2026
+20.6%
FY May 2025
+20.3%
FY May 2024
+20.2%
FY May 2023
+15.6%
FY May 2022
+7.3%
Aug 2026
+6.3%
May 2026
+20.8%
Feb 2026
+22.4%
Nov 2025
+17.3%
Aug 2025
+22.1%
May 2025
+23.7%
Feb 2025
+19.0%
Nov 2024
+12.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$12.1M
operating cash flow minus capex, 2025-09-01 to 2026-08-31
Free cash flow, TTM TAYD
FY May 2026
$4.9M
FY May 2025
$4.9M
FY May 2024
$12.1M
FY May 2023
$4.3M
FY May 2022
$1.9M
Aug 2026
$7.5M
May 2026
-$233.3K
Feb 2026
$381.7K
Nov 2025
$4.4M
Aug 2025
$298.6K
May 2025
$491.3K
Feb 2025
$8.8M
Nov 2024
-$620.5K
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity TAYD
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt TAYD
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+9.9%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on equity TAYD
FY May 2026
+12.7%
FY May 2025
+16.6%
FY May 2024
+17.8%
FY May 2023
+13.5%
FY May 2022
+5.3%
Aug 2026
+9.9%
May 2026
+12.7%
Feb 2026
+16.2%
Nov 2025
+16.1%
Aug 2025
+15.1%
May 2025
+16.6%
Feb 2025
+15.5%
Nov 2024
+16.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.0%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on assets TAYD
FY May 2026
+11.5%
FY May 2025
+14.0%
FY May 2024
+14.9%
FY May 2023
+11.7%
FY May 2022
+4.7%
Aug 2026
+9.0%
May 2026
+11.5%
Feb 2026
+14.3%
Nov 2025
+14.6%
Aug 2025
+13.5%
May 2025
+14.0%
Feb 2025
+13.1%
Nov 2024
+14.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -0%, not meaningful
Return on invested capital TAYD
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.5%
operating income (EBIT proxy) over average of 2025-08-31 and 2026-08-31 minus current liabilities
Return on capital employed TAYD
FY May 2026
+10.9%
FY May 2025
+17.0%
FY May 2024
+18.7%
FY May 2023
+14.6%
FY May 2022
+5.9%
Aug 2026
+7.5%
May 2026
+10.9%
Feb 2026
+16.5%
Nov 2025
+16.7%
Aug 2025
+15.2%
May 2025
+17.0%
Feb 2025
+15.9%
Nov 2024
+17.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing TAYD
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value TAYD
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield TAYD
FY May 2026
+3.0%
FY May 2025
+4.2%
FY May 2024
+7.7%
FY May 2023
+6.7%
FY May 2022
+5.9%
Aug 2026
+6.3%
May 2026
+3.0%
Feb 2026
+2.0%
Nov 2025
+9.0%
Aug 2025
+5.9%
May 2025
+4.2%
Feb 2025
+10.0%
Nov 2024
+0.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing TAYD
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
TAYD ranks highest on profitability (61st percentile) and risk and compliance (45th), and lowest on growth (13th), among Industrials peers.
Profitability
61
Inputs
Return on equity+9.9% · 54 pct, sector of 198
Return on assets+9.0% · 79 pct, sector of 224
Return on invested capitaleffective tax rate -0%, not meaningful
Return on capital employed+7.5% · 51 pct, sector of 195
Growth
13
Inputs
Revenue growth, YoY-10.0% · 13 pct, sector of 255
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
20
Inputs
Funds adding, latest quarter44 · 20 pct, sector of 200
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
45
Inputs
Short interest, % of float+4.5% · 45 pct, sector of 271
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Insider conviction, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.